Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. EHC
EHC logo

EHC Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
106.795
Open
106.140
VWAP
106.49
Vol
47.36K
Mkt Cap
10.53B
Low
105.990
Amount
5.04M
EV/EBITDA(TTM)
9.57
Total Shares
99.20M
EV
13.80B
EV/OCF(TTM)
11.70
P/S(TTM)
1.78
Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. It operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. It operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. It provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.
Show More

Events Timeline

(ET)
2026-03-18
16:50:00
Encompass Health to Build 40-Bed Rehabilitation Hospital in Delaware
select
2026-02-13 (ET)
2026-02-13
08:10:00
Encompass Health to Build 50-Bed Rehab Hospital in Mississippi
select
2026-02-12 (ET)
2026-02-12
09:30:00
Enhabit and Encompass Health Awarded $43.1M
select
2026-02-05 (ET)
2026-02-05
20:00:00
Amazon Falls Over 10% After Earnings Report
select
2026-02-05
16:40:00
Sees FY26 Revenue at $6.365B-$6.465B
select
2026-02-05
16:30:00
Company Reports Q4 Revenue of $1.54B
select
2025-12-02 (ET)
2025-12-02
21:30:00
Bitcoin Rebounds Supporting Market Stabilization; Multiple Companies Release Earnings
select

News

Yahoo Finance
7.5
05-08Yahoo Finance
Encompass Health Acquires Land for New Rehabilitation Hospital in Texas
  • Successful Land Transaction: Davidson Bogel Real Estate announces the successful sale of approximately 7 acres in Haslet, Texas, with buyer Encompass Health collaborating closely with landowner Terra Manna, highlighting the area's investment potential.
  • Hospital Construction Plans: Encompass Health plans to develop a state-of-the-art 50-bed inpatient rehabilitation hospital on the site, expected to significantly enhance specialized rehabilitative care access in the rapidly growing Haslet submarket to meet rising medical demands.
  • Catalyst for Regional Development: The establishment of the new hospital will not only provide much-needed medical services to the community but also serve as a catalyst for continued development in the surrounding area, further driving economic growth and infrastructure improvements in Haslet.
  • Market Leadership Position: Encompass Health is the nation's largest provider of inpatient rehabilitation services, treating approximately one in three patients in the U.S., and its commitment to clinical expertise and personalized care enhances its competitive advantage in the market.
PRnewswire
8.0
05-07PRnewswire
Encompass Health Declares Quarterly Cash Dividend
  • Quarterly Cash Dividend: Encompass Health's board has declared a cash dividend of $0.19 per share, payable on July 15, 2026, to shareholders of record on July 1, 2026, reflecting the company's commitment to returning value to its investors.
  • Industry Leadership: As the largest operator of inpatient rehabilitation hospitals in the U.S., Encompass Health operates 175 hospitals across 39 states and Puerto Rico, leveraging advanced technology and innovative treatments to provide high-quality rehabilitative care, thereby reinforcing its market leadership.
  • Honors and Recognition: The company has been recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista, and ranks among Fortune's World's Most Admired Companies™, Forbes' America's Best Companies, and Becker's Healthcare's Top Places to Work, enhancing its brand image and competitive position.
  • Forward-Looking Statements: The press release includes forward-looking statements regarding potential changes in dividend amounts and timing, highlighting the legal and regulatory risks faced in the healthcare industry, and reminding investors to consider potential uncertainties.
Newsfilter
8.5
05-05Newsfilter
Encompass Health Opens New Rehabilitation Hospital in Pennsylvania
  • New Hospital Opening: Encompass Health has launched a new 50-bed rehabilitation hospital in Concord Township, Delaware County, Pennsylvania, now accepting patients, marking a significant expansion in the region.
  • Comprehensive Services: The hospital offers rehabilitation services for conditions such as strokes, brain injuries, and spinal cord injuries, with patients receiving a minimum of 15 hours of intensive therapy weekly, aimed at restoring their functional abilities and quality of life.
  • Advanced Facilities: The hospital features private patient rooms, state-of-the-art therapy gyms, and activities of daily living suites designed to provide personalized rehabilitation experiences for patients of all mobility levels, enhancing recovery outcomes.
  • Strategic Expansion: This marks Encompass Health's tenth hospital in Pennsylvania, with plans to open another facility in Lower Providence, further solidifying its leadership position in the U.S. rehabilitation healthcare market.
Yahoo Finance
9.5
05-02Yahoo Finance
Encompass Health Reports Strong Q1 Earnings with Revenue Growth and Guidance Raise
  • Significant Revenue Growth: Encompass Health reported a 9% increase in Q1 revenue to $1.59 billion, with adjusted EBITDA rising 11.2% to $348.8 million, reflecting strong market performance and prompting an upward revision of 2026 guidance.
  • Improved Patient Outcomes: The discharge community rate improved by 50 basis points to 84.5%, exceeding industry averages, indicating significant progress in enhancing patient outcomes and strengthening the company's competitive position.
  • Optimized Human Resource Management: RN turnover decreased to 17.8%, the lowest since 2012, contributing to a 9.4% decline in premium labor spend, showcasing the company's successful strategies in employee retention and development.
  • Expansion Plans Implementation: The company plans to open 7 new hospitals and add 100 to 150 beds to existing facilities to meet strong demand for inpatient rehabilitation services, further solidifying its market position and enhancing service capacity.
seekingalpha
9.5
05-01seekingalpha
Encompass Health Reports Strong Q1 2026 Earnings Growth
  • Significant Revenue Growth: Encompass Health reported a 9% revenue increase in Q1 2026, reaching $1.59 billion, with adjusted EBITDA rising 11.2% to $348.8 million, indicating strong financial performance amid robust demand for healthcare services.
  • Accelerated Expansion Plans: The company plans to open seven more hospitals in 2026, adding a total of 340 beds and increasing existing hospital capacity by 100 to 150 beds, demonstrating its proactive approach to capacity expansion in response to strong market demand.
  • Cash Flow and Buybacks: Q1 adjusted free cash flow was $194 million, and the company repurchased approximately 708,000 shares for a total of $71.6 million, reflecting a balanced approach between expansion and shareholder returns.
  • Guidance Upgraded for 2026: Based on strong Q1 results, the company raised its 2026 net operating revenue guidance to $6.375 billion to $6.470 billion and adjusted EBITDA expectations to $1.35 billion to $1.38 billion, showcasing management's confidence in future performance.
seekingalpha
9.5
04-29seekingalpha
Encompass Health Q1 Earnings Announcement Scheduled
  • Earnings Release Date: Encompass Health (EHC) is set to announce its Q1 2023 earnings on April 30th after market close, with consensus EPS estimated at $1.49 and revenue at $1.57 billion, reflecting an 8.3% year-over-year growth, which could significantly impact the stock price.
  • Historical Performance: Over the past two years, EHC has beaten EPS estimates 100% of the time and revenue estimates 75% of the time, which bolsters investor confidence in the upcoming earnings report and reflects the company's strong operational performance.
  • Estimate Revision Dynamics: In the last three months, EPS estimates have seen six upward revisions and three downward revisions, while revenue estimates have faced no upward revisions but nine downward adjustments, indicating a potential weakening in market expectations for future revenue growth.
  • Future Outlook: Encompass Health targets up to $6.465 billion in revenue by 2026, driven by capacity expansion and regulatory adaptation, and achieving this goal will further enhance the company's market position in the healthcare sector.
Wall Street analysts forecast EHC stock price to rise
5 Analyst Rating
Wall Street analysts forecast EHC stock price to rise
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
134.00
Averages
146.75
High
160.00
Current: 0.000
sliders
Low
134.00
Averages
146.75
High
160.00
Barclays
NULL -> Overweight
maintain
$153 -> $140
AI Analysis
2026-05-05
Reason
Barclays
Price Target
$153 -> $140
AI Analysis
2026-05-05
maintain
NULL -> Overweight
Reason
Barclays lowered the firm's price target on Encompass Health to $140 from $153 and keeps an Overweight rating on the shares. The firm updated the company's model post the Q1 report. High occupancy rates may constrain Encompass' volume growth near-term, but there is evidence of further opportunity to meet demand with de novo development, the analyst tells investors in a research note.
BofA
analyst
Buy
maintain
$160 -> $150
2026-05-01
Reason
BofA
analyst
Price Target
$160 -> $150
2026-05-01
maintain
Buy
Reason
BofA lowered the firm's price target on Encompass Health to $150 from $160 and keeps a Buy rating on the shares. Q1 EBITDA beat by 3% despite weaker volumes, notes the analyst, who raised estimates following the report but trimmed the firm's target to reflect lower peer group multiples.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for EHC
Unlock Now

Valuation Metrics

The current forward P/E ratio for Encompass Health Corp (EHC.N) is 17.06, compared to its 5-year average forward P/E of 19.28. For a more detailed relative valuation and DCF analysis to assess Encompass Health Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
19.28
Current PE
17.06
Overvalued PE
21.35
Undervalued PE
17.21

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
10.80
Current EV/EBITDA
7.96
Overvalued EV/EBITDA
11.92
Undervalued EV/EBITDA
9.69

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.49
Current PS
1.53
Overvalued PS
1.73
Undervalued PS
1.24

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what other stocks should I buy and why
Intellectia · 14 candidates
Market Cap: >= 10.00BAnalyst Consensus: Strong Buy, Moderate BuyEps 5yr Cagr: >= 10Pe Ttm: 10 - 35Target Price Upside Potential: MoreAbovePriceOne Month Predict Return: >= 0.0%
Ticker
Name
Market Cap$
top bottom
PTC logo
PTC
PTC Inc
19.39B
MSFT logo
MSFT
Microsoft Corp
3.01T
NVO logo
NVO
Novo Nordisk A/S
171.90B
SEIC logo
SEIC
SEI Investments Co
10.00B
BMRN logo
BMRN
BioMarin Pharmaceutical Inc
11.62B
BR logo
BR
Broadridge Financial Solutions Inc
22.04B
what are the best stocks to buy today
Intellectia · 16 candidates
Market Cap: >= 10.00BRegion: USAnalyst Consensus: Strong Buy, Moderate BuyList Exchange: XNYS, XNAS, XASETarget Price Upside Potential: MoreAbovePriceMoving Average Relationship: PriceAboveMA20
Ticker
Name
Market Cap$
top bottom
NVDA logo
NVDA
NVIDIA Corp
4.65T
PDD logo
PDD
PDD Holdings Inc
150.14B
QCOM logo
QCOM
Qualcomm Inc
149.82B
SMFG logo
SMFG
Sumitomo Mitsui Financial Group, Inc
148.10B
SNY logo
SNY
Sanofi SA
114.04B
CEG logo
CEG
Constellation Energy Corp
106.46B
what stock to buy Monday
Intellectia · 5 candidates
Market Cap: >= 10.00BBeta: LowRisk, ModerateRiskWeekly Average Turnover: >= 1,000,000Rsi 14: <= 35Week Price Change Pct: >= $-1.00
Ticker
Name
Market Cap$
top bottom
ET logo
ET
Energy Transfer LP
60.60B
MPLX logo
MPLX
MPLX LP
56.57B
PAA logo
PAA
Plains All American Pipeline LP
13.48B
YMM logo
YMM
Full Truck Alliance Co Ltd
10.30B
EHC logo
EHC
Encompass Health Corp
10.00B
find similar stocks of hims and hers
Intellectia · 208 candidates
Market Cap: 300.00M - 15.00BPs Ratio: <= 15.00Is Optionable: TrueAnnual Revenue Yoy Growth: >= 0.0%
Ticker
Name
Market Cap$
top bottom
GH logo
GH
Guardant Health Inc
14.98B
ICLR logo
ICLR
ICON PLC
14.12B
PEN logo
PEN
Penumbra Inc
14.03B
SOLV logo
SOLV
Solventum Corp
13.94B
SNN logo
SNN
Smith & Nephew PLC
13.91B
NBIX logo
NBIX
Neurocrine Biosciences Inc
13.50B
share the top 100 instead of 12
Intellectia · 24 candidates
Market Cap: >= 1000.00MNet Margin: >= 10.00Weekly Average Turnover: >= 1,000,000Pe Ttm: 17 - 23Return On Equity: >= 18.0%Annual Revenue Yoy Growth: >= 10.0%
Ticker
Name
Market Cap$
top bottom
NVS logo
NVS
Novartis AG
278.44B
COIN logo
COIN
Coinbase Global Inc
61.19B
AU logo
AU
Anglogold Ashanti PLC
51.18B
KGC logo
KGC
Kinross Gold Corp
43.05B
FUTU logo
FUTU
Futu Holdings Ltd
23.11B
FTI logo
FTI
TechnipFMC PLC
21.93B

Whales Holding EHC

O
Oberweis Asset Management, Inc.
Holding
EHC
+45.80%
3M Return
S
Systematic Financial Management LP
Holding
EHC
+14.80%
3M Return
R
Reinhart Partners, LLC
Holding
EHC
+13.78%
3M Return
L
Leeward Investments, LLC
Holding
EHC
+6.91%
3M Return
T
Trillium Asset Management, LLC
Holding
EHC
+5.67%
3M Return
F
Fuller & Thaler Asset Management, Inc.
Holding
EHC
+4.80%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Encompass Health Corp (EHC) stock price today?

The current price of EHC is 106.68 USD — it has increased 0.55

What is Encompass Health Corp (EHC)'s business?

Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. It operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. It operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. It provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.

What is the price predicton of EHC Stock?

Wall Street analysts forecast EHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EHC is146.75 USD with a low forecast of 134.00 USD and a high forecast of 160.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Encompass Health Corp (EHC)'s revenue for the last quarter?

Encompass Health Corp revenue for the last quarter amounts to 1.59B USD, increased 9.01

What is Encompass Health Corp (EHC)'s earnings per share (EPS) for the last quarter?

Encompass Health Corp. EPS for the last quarter amounts to 1.93 USD, increased 30.41

How many employees does Encompass Health Corp (EHC). have?

Encompass Health Corp (EHC) has 24611 emplpoyees as of May 11 2026.

What is Encompass Health Corp (EHC) market cap?

Today EHC has the market capitalization of 10.53B USD.